To understand whether AML derived-EVs induced changes of HSPC differentiation, we analyzed by flow cytometer the frequency distribution of CD34+ progenitor cells treated or not with KG-1 or ME-1 EVs. This evidence concerns the gene CD34 and acute myeloid leukemia.